Our 2nd most downloaded article in 2022: Natural killer cells in antitumour adoptive cell immunotherapy by Katy Rezvani @lab_rezvani & colleagues https://t.co/yOg1eyipf7 @NatResCancer #NRCtop10of2022 https://t.co/8AfYecddKx
@UConnIM@RichardChamplin@EJShpallMD@DQBMD#BMT. Also, thanks to the rest of the faculty who are not on Twitter: Dr. Popat, Dr. Kebriaei, Dr. Alousi, Dr. Alatrash, Dr. Mehta, Dr. Ramdial, and Dr. Rondon.
Excited to present our study "Transplant Outcomes for TP53 Mutated AML and MDS in the Contemporary Era" in ASH22! Please visit poster session Hall D- Paper 4764 at #ASH22 to see our data. Grateful for the mentorship of Dr. Oran๐
https://t.co/yrOx91mPtt
#ASH22@MDAndersonNews
So excited to share that I will be starting my Hem/Onc fellowship next year at @NIHClinicalCntr !!
I feel extremely proud and honored to become a part of such an amazing team! @theNCI @nih_nhlbi @NIH Thanks to all of their support for @UConnIM